Does this help? From the FDA SSED, June 2021 expanded use approval
Results from the retrospective study provide sufficient initial evidence to support a 6-month shelf life for the RECELL® Device (based on available stability data provided for the activity of the Enzyme component). A prospective study assessing Enzyme stability will be performed to support future extension of the current 18-month shelf-life.
Ann: Quarterly Financial Report (Form 10-Q), page-43
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.76 |
Change
0.255(10.2%) |
Mkt cap ! $190.5M | |||
| Open | High | Low | Value | Volume |
| $2.51 | $2.80 | $2.51 | $1.270M | 476.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2672 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.76 | 4617 | 2 |
View Market Depth
| Last trade - 11.34am 09/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |